
    
      Forty hypertensive volunteers between 18 and 75 years will be recruited from the Winnipeg
      (Manitoba, Canada) area to participate in a two arm crossover, double-blind, randomized,
      placebo-controlled intervention study for 8 weeks per study period following obtainment of
      informed consent.

      The 2 periods of treatment will include:

        1. Treatment period: One capsule twice a day, providing 600 mg each of aged garlic extract
           powder, for a total of 1200 mg/day of aged garlic extract powder.

        2. Control period: The control product will be an identical-looking placebo capsules
           containing cellulose, which is being used as a filler in the treatment capsules.
    
  